Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Clinical evaluation and validation of laboratory methods for the diagnosis of Bordetella pertussis infection: Culture, polymerase chain reaction (PCR) and anti-pertussis toxin IgG serology (IgG-PT).

Lee AD, Cassiday PK, Pawloski LC, Tatti KM, Martin MD, Briere EC, Tondella ML, Martin SW; Clinical Validation Study Group.

PLoS One. 2018 Apr 13;13(4):e0195979. doi: 10.1371/journal.pone.0195979. eCollection 2018.

2.

Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape.

Wang L, Shi W, Chappell JD, Joyce MG, Zhang Y, Kanekiyo M, Becker MM, van Doremalen N, Fischer R, Wang N, Corbett KS, Choe M, Mason RD, Van Galen JG, Zhou T, Saunders KO, Tatti KM, Haynes LM, Kwong PD, Modjarrad K, Kong WP, McLellan JS, Denison MR, Munster VJ, Mascola JR, Graham BS.

J Virol. 2018 Apr 27;92(10). pii: e02002-17. doi: 10.1128/JVI.02002-17. Print 2018 May 15.

3.

Conveyance Contact Investigation for Imported Middle East Respiratory Syndrome Cases, United States, May 2014.

Lippold SA, Objio T, Vonnahme L, Washburn F, Cohen NJ, Chen TH, Edelson PJ, Gulati R, Hale C, Harcourt J, Haynes L, Jewett A, Jungerman R, Kohl KS, Miao C, Pesik N, Regan JJ, Roland E, Schembri C, Schneider E, Tamin A, Tatti K, Alvarado-Ramy F.

Emerg Infect Dis. 2017 Sep;23(9):1585-1589. doi: 10.3201/eid2309.170365.

4.

Human cathelicidin, LL-37, inhibits respiratory syncytial virus infection in polarized airway epithelial cells.

Harcourt JL, McDonald M, Svoboda P, Pohl J, Tatti K, Haynes LM.

BMC Res Notes. 2016 Jan 5;9:11. doi: 10.1186/s13104-015-1836-y.

5.

Multifacility Outbreak of Middle East Respiratory Syndrome in Taif, Saudi Arabia.

Assiri A, Abedi GR, Bin Saeed AA, Abdalla MA, al-Masry M, Choudhry AJ, Lu X, Erdman DD, Tatti K, Binder AM, Rudd J, Tokars J, Miao C, Alarbash H, Nooh R, Pallansch M, Gerber SI, Watson JT.

Emerg Infect Dis. 2016 Jan;22(1):32-40. doi: 10.3201/eid2201.151370.

6.

Comparative analytical evaluation of the respiratory TaqMan Array Card with real-time PCR and commercial multi-pathogen assays.

Harvey JJ, Chester S, Burke SA, Ansbro M, Aden T, Gose R, Sciulli R, Bai J, DesJardin L, Benfer JL, Hall J, Smole S, Doan K, Popowich MD, St George K, Quinlan T, Halse TA, Li Z, Pérez-Osorio AC, Glover WA, Russell D, Reisdorf E, Whyte T Jr, Whitaker B, Hatcher C, Srinivasan V, Tatti K, Tondella ML, Wang X, Winchell JM, Mayer LW, Jernigan D, Mawle AC.

J Virol Methods. 2016 Feb;228:151-7. doi: 10.1016/j.jviromet.2015.11.020. Epub 2015 Nov 27.

PMID:
26640122
7.

Qualitative assessment of pertussis diagnostics in United States laboratories.

Tatti KM, Martin SW, Boney KO, Brown K, Clark TA, Tondella ML.

Pediatr Infect Dis J. 2013 Sep;32(9):942-5. doi: 10.1097/INF.0b013e3182947ef8.

PMID:
23587980
8.

Draft genome sequences of Bordetella holmesii strains from blood (F627) and nasopharynx (H558).

Tatti KM, Loparev VN, Ranganathanganakammal S, Changayil S, Frace M, Weil MR, Sammons S, Maccannell D, Mayer LW, Tondella ML.

Genome Announc. 2013 Mar 21;1(2):e0005613. doi: 10.1128/genomeA.00056-13.

9.

Utilization of multiple real-time PCR assays for the diagnosis of Bordetella spp. in clinical specimens.

Tatti KM, Tondella ML.

Methods Mol Biol. 2013;943:135-47. doi: 10.1007/978-1-60327-353-4_9.

PMID:
23104287
10.

Epidemiologic and laboratory features of a large outbreak of pertussis-like illnesses associated with cocirculating Bordetella holmesii and Bordetella pertussis--Ohio, 2010-2011.

Rodgers L, Martin SW, Cohn A, Budd J, Marcon M, Terranella A, Mandal S, Salamon D, Leber A, Tondella ML, Tatti K, Spicer K, Emanuel A, Koch E, McGlone L, Pawloski L, Lemaile-Williams M, Tucker N, Iyer R, Clark TA, Diorio M.

Clin Infect Dis. 2013 Feb;56(3):322-31. doi: 10.1093/cid/cis888. Epub 2012 Oct 19.

PMID:
23087388
11.

Population diversity among Bordetella pertussis isolates, United States, 1935-2009.

Schmidtke AJ, Boney KO, Martin SW, Skoff TH, Tondella ML, Tatti KM.

Emerg Infect Dis. 2012 Aug;18(8):1248-55. doi: 10.3201/eid1808.120082.

12.

Serotypes and genetic profiles of Bordetella pertussis strains isolated in the city of São Paulo, 2006-2008.

Leite D, Cassiday PK, Tatti KM, Vaz TM, Tondella ML.

J Pediatr (Rio J). 2012 Jul;88(4):357-60. doi: 10.2223/JPED.2186. Epub 2012 May 23.

13.

Pertussis Pseudo-outbreak linked to specimens contaminated by Bordetella pertussis DNA From clinic surfaces.

Mandal S, Tatti KM, Woods-Stout D, Cassiday PK, Faulkner AE, Griffith MM, Jackson ML, Pawloski LC, Wagner B, Barnes M, Cohn AC, Gershman KA, Messonnier NE, Clark TA, Tondella ML, Martin SW.

Pediatrics. 2012 Feb;129(2):e424-30. doi: 10.1542/peds.2011-1710. Epub 2012 Jan 16.

PMID:
22250029
14.

Novel multitarget real-time PCR assay for rapid detection of Bordetella species in clinical specimens.

Tatti KM, Sparks KN, Boney KO, Tondella ML.

J Clin Microbiol. 2011 Dec;49(12):4059-66. doi: 10.1128/JCM.00601-11. Epub 2011 Sep 21.

15.

Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis.

Wei SC, Tatti K, Cushing K, Rosen J, Brown K, Cassiday P, Clark T, Olans R, Pawloski L, Martin M, Tondella ML, Martin SW.

Clin Infect Dis. 2010 Aug 1;51(3):315-21. doi: 10.1086/653938.

PMID:
20578875
16.

A computational genomics pipeline for prokaryotic sequencing projects.

Kislyuk AO, Katz LS, Agrawal S, Hagen MS, Conley AB, Jayaraman P, Nelakuditi V, Humphrey JC, Sammons SA, Govil D, Mair RD, Tatti KM, Tondella ML, Harcourt BH, Mayer LW, Jordan IK.

Bioinformatics. 2010 Aug 1;26(15):1819-26. doi: 10.1093/bioinformatics/btq284. Epub 2010 Jun 2.

17.

Pathology and pathogenesis of fatal Bordetella pertussis infection in infants.

Paddock CD, Sanden GN, Cherry JD, Gal AA, Langston C, Tatti KM, Wu KH, Goldsmith CS, Greer PW, Montague JL, Eliason MT, Holman RC, Guarner J, Shieh WJ, Zaki SR.

Clin Infect Dis. 2008 Aug 1;47(3):328-38. doi: 10.1086/589753.

PMID:
18558873
18.

Development and evaluation of dual-target real-time polymerase chain reaction assays to detect Bordetella spp.

Tatti KM, Wu KH, Tondella ML, Cassiday PK, Cortese MM, Wilkins PP, Sanden GN.

Diagn Microbiol Infect Dis. 2008 Jul;61(3):264-72. doi: 10.1016/j.diagmicrobio.2008.02.017. Epub 2008 Apr 25.

PMID:
18440175
19.

Real-time polymerase chain reaction detection of Bordetella pertussis DNA in acellular pertussis vaccines.

Tatti KM, Slade B, Patel M, Messonnier N, Jackson T, Kirkland KB, Talbot EA, Tondella ML.

Pediatr Infect Dis J. 2008 Jan;27(1):73-4.

PMID:
18162945
20.

Molecular diagnosis of Nocardia farcinica from a cerebral abscess.

Tatti KM, Shieh WJ, Phillips S, Augenbraun M, Rao C, Zaki SR.

Hum Pathol. 2006 Aug;37(8):1117-21. Epub 2006 May 22.

PMID:
16867876
21.

Morphologic, immunologic, and molecular methods to detect bacillus anthracis in formalin-fixed tissues.

Tatti KM, Greer P, White E, Shieh WJ, Guarner J, Ferebee-Harris T, Bartlett J, Ashford D, Hoffmaster A, Gallucci G, Vafai A, Popovic T, Zaki SR.

Appl Immunohistochem Mol Morphol. 2006 Jun;14(2):234-43.

PMID:
16785797
22.

Intussusception after administration of the rhesus tetravalent rotavirus vaccine (Rotashield): the search for a pathogenic mechanism.

Lynch M, Shieh WJ, Bresee JS, Tatti KM, Gentsch JR, Jones T, Jiang B, Hummelman E, Zimmerman CM, Zaki SR, Glass RI.

Pediatrics. 2006 May;117(5):e827-32.

PMID:
16651287
23.

Molecular diagnosis of Bordetella pertussis infection by evaluation of formalin-fixed tissue specimens.

Tatti KM, Wu KH, Sanden GN, Greer P, Sumner J, Guarner J, Paddock CD, Zaki SR.

J Clin Microbiol. 2006 Mar;44(3):1074-6.

24.

Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan.

Shieh WJ, Hsiao CH, Paddock CD, Guarner J, Goldsmith CS, Tatti K, Packard M, Mueller L, Wu MZ, Rollin P, Su IJ, Zaki SR.

Hum Pathol. 2005 Mar;36(3):303-9.

PMID:
15791576
25.

Ultrastructural characterization of SARS coronavirus.

Goldsmith CS, Tatti KM, Ksiazek TG, Rollin PE, Comer JA, Lee WW, Rota PA, Bankamp B, Bellini WJ, Zaki SR.

Emerg Infect Dis. 2004 Feb;10(2):320-6.

26.

Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice.

Subbarao K, McAuliffe J, Vogel L, Fahle G, Fischer S, Tatti K, Packard M, Shieh WJ, Zaki S, Murphy B.

J Virol. 2004 Apr;78(7):3572-7.

27.

The pathology of rotavirus-associated deaths, using new molecular diagnostics.

Lynch M, Shieh WJ, Tatti K, Gentsch JR, Ferebee-Harris T, Jiang B, Guarner J, Bresee JS, Greenwald M, Cullen S, Davies HD, Trevenen C, Zaki SR, Glass RI.

Clin Infect Dis. 2003 Nov 15;37(10):1327-33. Epub 2003 Oct 23.

PMID:
14583866
28.

The critical role of pathology in the investigation of bioterrorism-related cutaneous anthrax.

Shieh WJ, Guarner J, Paddock C, Greer P, Tatti K, Fischer M, Layton M, Philips M, Bresnitz E, Quinn CP, Popovic T, Perkins BA, Zaki SR; Anthrax Bioterrorism Investigation Team.

Am J Pathol. 2003 Nov;163(5):1901-10.

29.

Pathology and pathogenesis of bioterrorism-related inhalational anthrax.

Guarner J, Jernigan JA, Shieh WJ, Tatti K, Flannagan LM, Stephens DS, Popovic T, Ashford DA, Perkins BA, Zaki SR; Inhalational Anthrax Pathology Working Group.

Am J Pathol. 2003 Aug;163(2):701-9.

30.

Molecular and immunological methods to detect rotavirus in formalin-fixed tissue.

Tatti KM, Gentsch J, Shieh WJ, Ferebee-Harris T, Lynch M, Bresee J, Jiang B, Zaki SR, Glass R.

J Virol Methods. 2002 Sep;105(2):305-19.

PMID:
12270663
31.

Mutations in the conserved woodchuck hepatitis virus polymerase FLLA and YMDD regions conferring resistance to lamivudine.

Tatti KM, Korba BE, Stang HL, Peek S, Gerin JL, Tennant BC, Schinazi RF.

Antiviral Res. 2002 Jul;55(1):141-50.

PMID:
12076758
32.

Cellular replication of human immunodeficiency virus type 1 occurs in vaginal secretions.

Ellerbrock TV, Lennox JL, Clancy KA, Schinazi RF, Wright TC, Pratt-Palmore M, Evans-Strickfaden T, Schnell C, Pai R, Conley LJ, Parrish-Kohler EE, Bush TJ, Tatti K, Hart CE.

J Infect Dis. 2001 Jul 1;184(1):28-36. Epub 2001 May 30.

PMID:
11398106
33.

A rapid non-culture-based assay for clinical monitoring of phenotypic resistance of human immunodeficiency virus type 1 to lamivudine (3TC).

García Lerma J, Schinazi RF, Juodawlkis AS, Soriano V, Lin Y, Tatti K, Rimland D, Folks TM, Heneine W.

Antimicrob Agents Chemother. 1999 Feb;43(2):264-70.

34.

RNA polymerase sigma factors of Bacillus subtilis: purification and characterization.

Tatti KM, Moran CP Jr.

Methods Enzymol. 1996;273:149-62. Review. No abstract available.

PMID:
8791608
35.
36.

Sequence-specific interactions between promoter DNA and the RNA polymerase sigma factor E.

Tatti KM, Shuler MF, Moran CP Jr.

J Mol Biol. 1995 Oct 13;253(1):8-16.

PMID:
7473719
37.

A single amino acid substitution in sigma E affects its ability to bind core RNA polymerase.

Shuler MF, Tatti KM, Wade KH, Moran CP Jr.

J Bacteriol. 1995 Jul;177(13):3687-94.

38.

Genetic suppression analysis of sigma E interaction with three promoters in sporulating Bacillus subtilis.

Diederich B, Tatti KM, Jones CH, Beall B, Moran CP Jr.

Gene. 1992 Nov 2;121(1):63-9.

PMID:
1427099
39.
40.

Genetic evidence for interaction of sigma E with the spoIIID promoter in Bacillus subtilis.

Tatti KM, Jones CH, Moran CP Jr.

J Bacteriol. 1991 Dec;173(24):7828-33.

41.

Transcription of the Bacillus subtilis spoIIA locus.

Wu JJ, Piggot PJ, Tatti KM, Moran CP Jr.

Gene. 1991 May 15;101(1):113-6.

PMID:
1905664
42.

Cloning of a promoter used by sigma H RNA polymerase in Bacillus subtilis.

Carter HL 3rd, Tatti KM, Moran CP Jr.

Gene. 1990 Nov 30;96(1):101-5.

PMID:
1702397
43.

Sigma H-directed transcription of citG in Bacillus subtilis.

Tatti KM, Carter HL 3rd, Moir A, Moran CP Jr.

J Bacteriol. 1989 Nov;171(11):5928-32.

44.

Genetic analysis of RNA polymerase-promoter interaction during sporulation in bacillus subtilis.

Ray C, Tatti KM, Jones CH, Moran CP Jr.

J Bacteriol. 1987 May;169(5):1807-11.

45.

Promoter used by sigma-29 RNA polymerase from Bacillus subtilis.

Hay RE, Tatti KM, Vold BS, Green CJ, Moran CP Jr.

Gene. 1986;48(2-3):301-6.

PMID:
3104146
46.

Utilization of one promoter by two forms of RNA polymerase from Bacillus subtilis.

Tatti KM, Moran CP Jr.

Nature. 1985 Mar 14-20;314(6007):190-2.

PMID:
3919317
47.

Promoter specificity of a sporulation-induced form of RNA polymerase from Bacillus subtilis.

Tatti KM, Kenney TJ, Hay RE, Moran CP Jr.

Gene. 1985;36(1-2):151-7.

PMID:
3934043
48.

Promoter recognition by sigma-37 RNA polymerase from Bacillus subtilis.

Tatti KM, Moran CP Jr.

J Mol Biol. 1984 May 25;175(3):285-97.

PMID:
6202876
49.
50.

Rapid purification of yeast mitochondrial DNA in high yield.

Hudspeth ME, Shumard DS, Tatti KM, Grossman LI.

Biochim Biophys Acta. 1980 Dec 11;610(2):221-8.

Supplemental Content

Support Center